You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Loperamide

Showing 1 - 25 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial (pyrotinib maleate, Loperamide)

Completed
  • Healthy Participants
  • pyrotinib maleate
  • Loperamide
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 27, 2022

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • (no location specified)
Aug 5, 2022

Diarrhoea;Acute, Diarrhea Travelers Trial in Djibouti, Comayagua, Nanyuki (Rifaximin 550 MG, Azithromycin 500 MG, Loperamide)

Recruiting
  • Diarrhoea;Acute
  • Diarrhea Travelers
  • Rifaximin 550 MG
  • +2 more
  • Djibouti, Djibouti
  • +2 more
Jan 9, 2023

LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

Not yet recruiting
  • LARS - Low Anterior Resection Syndrome
  • Seoul, Jongro-gu, Korea, Republic of
    Seoul National University Hospital
Dec 13, 2022

HER2-positive Recurrent / Metastatic Breast Cancer Trial (pyrotinib tablet, Montmorillonite Power, Loperamide)

Not yet recruiting
  • HER2-positive Recurrent / Metastatic Breast Cancer
  • pyrotinib tablet
  • +2 more
  • (no location specified)
Feb 16, 2022

Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Oct 31, 2022

Chemo-related Diarrhea Trial in Hangzhou (Prebiotic Fiber Supplement + loperamide HCl capsule, Maltodextrin + loperamide HCl

Withdrawn
  • Chemotherapy-related Diarrhea
  • Prebiotic Fiber Supplement + loperamide hydrochloride capsule
  • Maltodextrin + loperamide hydrochloride capsule
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, Zhejiang University School of Medici
Aug 1, 2021

HER2-positive Breast Cancer Trial (Neratinib)

Not yet recruiting
  • HER2-positive Breast Cancer
  • (no location specified)
Nov 29, 2021

Breast Cancer Trial in Tianjin (Loperamide, Loperamide and golden bifid, Loperamide and montmorillonite powder)

Recruiting
  • Breast Cancer
  • Loperamide
  • +2 more
  • Tianjin, China
    TianJin Medical University Cancer Institute and Hospital
Jan 28, 2021

Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)

Recruiting
  • Colitis
  • +8 more
  • Fecal Microbiota Transplantation
  • Loperamide
  • Houston, Texas
    M D Anderson Cancer Center
Oct 17, 2022

HER2 Amplified Breast Cancer Trial in Lisboa (Neratinib, Capecitabine, Loperamide)

Completed
  • HER2 Amplified Breast Cancer
  • Lisboa, Portugal
    Hospital CUF Descobertas
Apr 4, 2022

Intestinal Transit Trial in Plymouth (Loperamide, Senna)

Active, not recruiting
  • Intestinal Transit
  • Plymouth, United Kingdom
    Derriford Hospital
Oct 7, 2021

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Healthy Trial in Saint-Petersburg (Combination Caplet with Loperamide HCl and Simethicone, Loperamide HCl, Simethicone)

Completed
  • Healthy
  • Combination Caplet with Loperamide HCl and Simethicone
  • +2 more
  • Saint-Petersburg, Russian Federation
    "Scientific and Research centre Eco-safety" Limited Liability Co
Sep 8, 2020

Early Stage HER2+ Breast Cancer Trial in Worldwide (Neratinib, Loperamide, Colestipol)

Completed
Has Results
  • Early Stage HER2+ Breast Cancer
  • Birmingham, Alabama
  • +57 more
Apr 12, 2022

Low Anterior Resection Syndrome Trial in Stockholm (Transanal irrigation, Medication)

Active, not recruiting
  • Low Anterior Resection Syndrome
  • Stockholm, Sweden
  • +2 more
Aug 12, 2021

Colorectal Cancer, Diarrhea Trial in United States (loperamide HCl, octreotide acetate)

Completed
  • Colorectal Cancer
  • Diarrhea
  • loperamide hydrochloride
  • octreotide acetate
  • La Jolla, California
  • +32 more
Oct 29, 2020

Opioid Withdrawal Trial in St.-Petersburg (Pregabalin, Clonidine, Doxylamin)

Completed
  • Opioid Withdrawal
  • St.-Petersburg, Russian Federation
    St.-Petersburg Bekhterev Reserach Psychoneurological Institute
Apr 4, 2020

Drug Effects Trial in Saint Louis ([11C] desmethyl-loperamide, Control - no pretreatment, Oral ritonavir)

Completed
Has Results
  • Drug Effects
  • [11C] desmethyl-loperamide
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 8, 2020

Low Anterior Resection Syndrome Trial in Vilnius (Transanal irrigation, Best supportive care)

Recruiting
  • Low Anterior Resection Syndrome
  • Transanal irrigation
  • Best supportive care
  • Vilnius, Lithuania
    National Cancer Institute
Jun 27, 2023

Pediatric Cancer, Solid Tumor Trial in Esplugues De Llobregat (Acupuncture)

Recruiting
  • Pediatric Cancer
  • Solid Tumor
  • Acupuncture
  • Esplugues De Llobregat, Barcelona, Spain
    Hospital Sant Joan de Deu
Aug 18, 2022

Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)

Recruiting
  • Advanced Solid Tumors
  • Kirsten Rat Sarcoma (KRAS) pG12C Mutation
  • Tucson, Arizona
  • +83 more
Dec 28, 2022

Faecal Incontinence Trial in London (High Resolution Anorectal Manometry, Endoanal Ultrasound, Bowel diary)

Recruiting
  • Faecal Incontinence
  • High Resolution Anorectal Manometry
  • +7 more
  • London, United Kingdom
    The Functional Gut Clinic
Jun 1, 2023

Short Bowel Syndrome Trial in Poznan, Skawina, Lódz (Enteric-Coated Cholestyramine (ECC) Capsule, Placebo)

Terminated
Has Results
  • Short Bowel Syndrome
  • Enteric-Coated Cholestyramine (ECC) Capsule
  • Placebo
  • Poznań, Poland
  • +2 more
Jun 23, 2022

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jul 10, 2023